Cargando…

Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics

Congenital heart disease is one of the most common causes of death derived from malformations. Historically, its treatment has depended on timely diagnosis and early pharmacological and surgical interventions. Survival rates for patients with this disease have increased, primarily due to advancement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varela-Chinchilla, Carlos Daniel, Sánchez-Mejía, Daniela Edith, Trinidad-Calderón, Plinio A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316572/ https://www.ncbi.nlm.nih.gov/pubmed/35877563 http://dx.doi.org/10.3390/jcdd9070201

Ejemplares similares

Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics
por: Trinidad-Calderón, Plinio A., et al.
Publicado: (2021)

Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials
por: Trinidad-Calderón, Plinio A., et al.
Publicado: (2023)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

State-of-the-Art CT Imaging Techniques for Congenital Heart Disease
por: Goo, Hyun Woo
Publicado: (2010)

Management of Congenital Heart Disease: State of the Art—Part II—Cyanotic Heart Defects
por: Rao, P. Syamasundar
Publicado: (2019)

Management of Congenital Heart Disease: State of the Art; Part I—ACYANOTIC Heart Defects
por: Rao, P. Syamasundar
Publicado: (2019)

Congenital Toxoplasmosis: The State of the Art
por: Bollani, Lina, et al.
Publicado: (2022)

Percutaneous Structural Interventions in Adult Congenital Heart Disease: State-of-the-Art Review
por: Bou-Chaaya, Rody G., et al.
Publicado: (2023)

Aproximación al arte Maya /
por: Samayoa Chinchilla, Carlos. 1898-1973
Publicado: (1964)

Pharmacological treatments in ARDS; a state-of-the-art update
por: Boyle, Andrew James, et al.
Publicado: (2013)

Congenital Cytomegalovirus and Hearing Loss: The State of the Art
por: Aldè, Mirko, et al.
Publicado: (2023)

State of the art: 3D printing for creating compliant patient-specific congenital heart defect models
por: Schrot, Janelle, et al.
Publicado: (2014)

Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art
por: Esposito, Susanna, et al.
Publicado: (2021)

Congenital disorders of glycosylation (CDG): state of the art in 2022
por: Francisco, Rita, et al.
Publicado: (2023)

Congenital cytomegalovirus infection: the state of the art and future perspectives
por: Salomè, S., et al.
Publicado: (2023)

State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
por: Cho, Yongin, et al.
Publicado: (2022)

State of the Art of Pharmacological Activators of p53 in Ocular Malignancies
por: Casciano, Fabio, et al.
Publicado: (2023)

Therapeutic siRNA: state of the art
por: Hu, Bo, et al.
Publicado: (2020)

Textos de historia del arte
por: Plinio, el Viejo
Publicado: (2001)

Textos de historia del arte
por: Plinio, el Viejo
Publicado: (1987)

Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art
por: Savarino, Vincenzo, et al.
Publicado: (2021)

State-of-the-art Structural Interventions in Heart Failure
por: Park, Jeffrey, et al.
Publicado: (2019)

Frailty and heart failure: State‐of‐the‐art review
por: Talha, Khawaja M., et al.
Publicado: (2023)

Glioblastoma multiforme: State of the art and future therapeutics
por: Wilson, Taylor A., et al.
Publicado: (2014)

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)

Strophanthus (Hispidus): Its Pharmacology and Therapeutics
por: Purdy, Charles W.
Publicado: (1887)

Phytoestrogens in Postmenopause: The State of the Art from a Chemical, Pharmacological and Regulatory Perspective
por: Poluzzi, Elisabetta, et al.
Publicado: (2014)

Unveiling the Pharmacological and Nanotechnological Facets of Daidzein: Present State-of-the-Art and Future Perspectives
por: Singh, Sukhbir, et al.
Publicado: (2023)

nurP28, a New-to-Nature Zein-Derived Peptide, Enhances the Therapeutic Effect of Docetaxel in Breast Cancer Monolayers and Spheroids
por: Trinidad-Calderón, Plinio Alejandro, et al.
Publicado: (2022)

State-of-the-Art Management of Complications of Myeloma and Its Treatment
por: Hartley-Brown, Monique A., et al.
Publicado: (2010)

Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria
por: Bernardo-Seisdedos, Ganeko, et al.
Publicado: (2021)

Current state of the art in hypoplastic left heart syndrome
por: Birla, Aditya K., et al.
Publicado: (2022)

Neurogenic Orthostatic Hypotension: State of the Art and Therapeutic Strategies
por: Kalra, Dinesh K, et al.
Publicado: (2020)

Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
por: Basile, Maria Sofia, et al.
Publicado: (2019)

The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art
por: Zahedipour, Fatemeh, et al.
Publicado: (2021)

Therapeutic siRNA: State-of-the-Art and Future Perspectives
por: Friedrich, Maik, et al.
Publicado: (2022)

Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
por: Pitiot, Aubin, et al.
Publicado: (2022)

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
por: Diotallevi, Federico, et al.
Publicado: (2023)

State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan
por: Yamaguchi, Junichi, et al.
Publicado: (2023)

‘Making the Invisible Visible’: an audience response to an art installation representing the complexity of congenital heart disease and heart transplantation
por: Biglino, Giovanni, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ithq2cdt4kttq6g4bhoq76p31q